|Bid||95.00 x 800|
|Ask||107.94 x 1400|
|Day's Range||102.71 - 106.08|
|52 Week Range||78.97 - 106.08|
|PE Ratio (TTM)||28.56|
|Earnings Date||Jul 18, 2018 - Jul 23, 2018|
|Forward Dividend & Yield||0.64 (0.64%)|
|1y Target Est||113.07|
In the meantime, the state-owned oil company will fine-tune its portfolio to be the most attractive it can be. The world's biggest oil company said Thursday, July 19, it was pondering an investment in Saudi Basic Industries Corp., or Sabic, as part of a strategy "of rebalancing its portfolio by moving further into downstream and the petrochemical sector." Riyadh-based Sabic is the world's No. 4 chemicals company and could provide Saudi Aramco with a ready-made, and politically palatable, route to quickly expand its exposure to the petroleum-based chemicals that are a key market for its crude. It would provide access to revenue streams and operational expertise outside of Saudi Arabia via Sabic's overseas investments, which include a $2.5 billion, 25% stake, in Swiss petrochemicals group Clariant AG, that was acquired in January.
Stocks fell on Thursday after data in the Fed's "Beige Book" report suggested trade-war concerns are affecting corporate investment decisions and as earnings season kicked into high gear.
Danaher Corp said on Thursday it expects an earnings impact of a cent per quarter from the U.S.-China trade tariff dispute. While, the company in an earnings call with analysts did not say for how long ...
shares surged to an all-time high Thursday after the medical equipment maker said it would spin off its dental business into a separate, publicly-listed company. Danaher said the deal, which will close in the second half of next year, will be run by its current boss, Amir Aghdaei, who has guided that portion of the business to sale of around $3 billion a year, around 16% of Danaher's overall group sales. "We had an outstanding second quarter, with the team delivering results ahead of expectations," said CEO Thomas Joyce.
Corp. (DHR) on Thursday said it plans to spin off its dental segment into an independent, publicly traded company. The Washington science and technology company also reported better-than-expected second-quarter earnings. Danaher said the dental segment, which includes Nobel Biocare, Ormco and KaVo Kerr, had sales of $2.8 billion in 2017.
Among the companies with shares expected to trade actively in Thursday's session are Comcast, IBM, American Express, Tesla, Blackstone and Travelers.
Medical equipment maker Danaher Corp said on Thursday that it plans to spin off its dental business, which had annual sales of nearly $3 billion in 2017, into a publicly traded company. The transaction will be tax-free to Danaher shareholders and is expected to be completed in the second half of 2019. Amir Aghdaei, who is currently responsible for the dental business, will become the CEO of the new company, Danaher said.
Medical device maker Danaher Corp said on Thursday that it plans to spin-off its dental business, which had annual sales of nearly $3 billion in 2017, into a publicly traded company. The transaction will ...
The Washington-based company said it had net income of 95 cents per share. Earnings, adjusted for one-time gains and costs, came to $1.15 per share. The results surpassed Wall Street expectations. The ...
WASHINGTON , July 19, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the second quarter 2018. For the quarter ended June 29, 2018 , net earnings were $673.8 million , ...
WASHINGTON, July 19, 2018 /PRNewswire/ -- Danaher Corporation (DHR) today announced its intention to spin off its Dental segment into an independent, publicly-traded company ("DentalCo"). The transaction is intended to be tax-free to Danaher shareholders and expected to be completed in the second half of 2019. "This is an important step towards realizing even greater potential for both Danaher and our Dental business," said Thomas P. Joyce, Jr., President & Chief Executive Officer.
NEW YORK, NY / ACCESSWIRE / July 19, 2018 / Danaher Corporation (NYSE: DHR ) will be discussing their earnings results in their Q2 Earnings Call to be held on July 19, 2018 at 8:00 AM Eastern Time. To ...
Danaher's (DHR) Q2 earnings will likely reflect negative impact of Dental segment's prevalent supply-chain issues and rising cost. However, benefits of DBS implementation might turn things in favor.
GE unveiled plans to restructure the organization of its businesses and cut corporate costs, with a leading industry figure on hand to help.
healthcare unit could affect the consolidation landscape in the tools and medical devices sector, according to Evercore ISI analysts. Boston-based GE on Tuesday, June 26, unveiled plans to spin off the unit, which provides medical imaging, monitoring, biomanufacturing and cell therapy technology. "So while the healthcare investment community gains another sizable new asset (Siemens is also in process of unlocking with Healthineers), a major M&A chip is now off the table most likely," they added.
In this morning's lineup are: Cummins Inc. (NYSE: CMI), Danaher Corp. (NYSE: DHR), Donaldson Co. Inc. (NYSE: DCI), and Dover Corp. (NYSE: DOV). Columbus, Indiana headquartered Cummins Inc.'s stock finished Thursday's session 2.41% lower at $135.24 with a total trading volume of 1.53 million shares.
Investors pursuing a solid, dependable stock investment can often be led to Danaher Corporation (NYSE:DHR), a large-cap worth US$69.88b. Doing business globally, large caps tend to have diversified revenue streamsRead More...